Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The role of mucin 1 in respiratory diseases

Beatriz Ballester, Javier Milara, Julio Cortijo
European Respiratory Review 2021 30: 200149; DOI: 10.1183/16000617.0149-2020
Beatriz Ballester
1Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Aurora, CO, USA
2CIBERES, Health Institute Carlos III, Valencia, Spain
7Both authors contributed equally to this work
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: beatriz.2.ballester-llobell@cuanschutz.edu
Javier Milara
2CIBERES, Health Institute Carlos III, Valencia, Spain
3Pharmacy Unit, Consorcio Hospital General de Valencia, Valencia, Spain
4Pharmacology Dept, University Jaume I, Castellon, Spain
7Both authors contributed equally to this work
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Cortijo
2CIBERES, Health Institute Carlos III, Valencia, Spain
5Research and teaching Unit, Consorcio Hospital General de Valencia, Valencia, Spain
6Dept of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 30 no. 159
DOI 
https://doi.org/10.1183/16000617.0149-2020
PubMed 
33536260

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received May 15, 2020
  • Accepted September 4, 2020
  • Published online February 2, 2021.

Copyright & Usage 
Copyright ©ERS 2021. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Beatriz Ballester1,2,7⇑,
  2. Javier Milara2,3,4,7 and
  3. Julio Cortijo2,5,6
  1. 1Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Aurora, CO, USA
  2. 2CIBERES, Health Institute Carlos III, Valencia, Spain
  3. 3Pharmacy Unit, Consorcio Hospital General de Valencia, Valencia, Spain
  4. 4Pharmacology Dept, University Jaume I, Castellon, Spain
  5. 5Research and teaching Unit, Consorcio Hospital General de Valencia, Valencia, Spain
  6. 6Dept of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain
  7. 7Both authors contributed equally to this work
  1. Beatriz Ballester, Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Aurora, CO 80045, USA. E-mail: beatriz.2.ballester-llobell{at}cuanschutz.edu
View Full Text

Funding

  • Ministerio de Ciencia e Innovación

    CB06/06/0027; FEDER; JR18/00050; SAF2017–82913-R; TRA2009–0311
  • Generalitat Valenciana

    2017/023/UV; ACIF/2016/341
  • Instituto de Salud Carlos III

    FIS PI17/02158

Article usage

Article usage: February 2021 to July 2022

AbstractFullPdf
Feb 202113483175
Mar 2021816094
Apr 20211315885
May 2021411648
Jun 2021612949
Jul 202188956
Aug 202187953
Sep 202169954
Oct 20211212588
Nov 2021512577
Dec 2021159042
Jan 2022117838
Feb 2022614349
Mar 2022510853
Apr 2022612051
May 202298752
Jun 202219948
Jul 2022410041

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 30 Issue 159 Table of Contents
European Respiratory Review: 30 (159)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of mucin 1 in respiratory diseases
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The role of mucin 1 in respiratory diseases
Beatriz Ballester, Javier Milara, Julio Cortijo
European Respiratory Review Mar 2021, 30 (159) 200149; DOI: 10.1183/16000617.0149-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The role of mucin 1 in respiratory diseases
Beatriz Ballester, Javier Milara, Julio Cortijo
European Respiratory Review Mar 2021, 30 (159) 200149; DOI: 10.1183/16000617.0149-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • MUC1 overview
    • MUC1 and airway inflammation and infection
    • MUC1 and chronic rhinosinusitis with nasal polyps
    • MUC1 and asthma
    • MUC1 and COPD
    • MUC1 and lung cancer
    • MUC1 and interstitial lung disease
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Mechanisms of lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Biologic drugs in treating ABPA in patients with CF
  • Immune processes in the pathogenesis of chronic lung allograft dysfunction
  • Lung cancer occurrence after an episode of TB
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2022 by the European Respiratory Society